Tokyo, Sept. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062879) titled 'Translational Research of the FIRST-RCC Study: A Multicenter Retrospective Study on the Efficacy and Safety of First-Line Treatment with Nivolumab plus Cabozantinib or Pembrolizumab plus Lenvatinib for Advanced or Metastatic Renal Cell Carcinoma' on Sept. 10.
Study Type:
Observational
Primary Sponsor:
Institute - Yokohama City University
Condition:
Condition - Kidney cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - The FIRST-RCC study is a multicenter retrospective observational study evaluating the efficacy and safety of first-line treatment with nivo...